Active Ingredient: FINERENONE
Proprietary Name: KERENDIA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215341
Product Number: 002
Approval Date: Jul 9, 2021
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
